Smoking Cessation 12 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet
1 INDICATIONS AND USAGE Bupropion hydrochloride extended-release tablets (SR) are indicated as an aid to smoking cessation treatment. Bupropion hydrochloride extended-release tablets (SR) are an aminoketone agent indicated as an aid to smoking cessation treatment. ( 1 )
actavis pharma, inc.
ROUND WHITE WPI 867
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
BUPROPION HYDROCHLORIDE Extended-Release Tablets, USP (SR) 150 mg of
BUPROPION HYDROCHLORIDE, USP are white to off-white, round, unscored, film-coated tablets imprinted with "WPI" over "867" on one side and supplied in bottles of 60 tablets (NDC 0591-3543-60) and the Starter Pack containing 1 bottle of 60 tablets (NDC 0591-3543-76). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture.
More pills like ROUND WPI 867